| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1807 | 63 | 60 | 14 |
Expert Opinion on Emerging Drugs primarily tackles Internal medicine, Intensive care medicine, Immunology, Pharmacology and Disease. Topics in Internal medicine explored in it were investigated in conjunction with research in Gastroenterology, Endocrinology and Oncology. The studies on Oncology discussed can also contribute to research in the domains of Bevacizumab and Chemotherapy.
Some problems in Intensive care medicine that were presented in the journal overlapped with concepts under Clinical trial, MEDLINE, Pharmacotherapy, Physical therapy and Drug. The study on Clinical trial presented is investigated in conjunction with research in Drug development. The journal features research on Pharmacotherapy in an attempt to reinforce studies in the field of Psychiatry.
Research on Immunology addressed in it frequently intersections with the field of Virology. Expert Opinion on Emerging Drugs focuses on Pharmacology but sometimes tackles the closely related topic of Cancer research which is concerned with Tyrosine kinase. Disease and Bioinformatics are closely related fields of research discussed in the journal.
The most cited articles are mainly concerned with subjects like Pharmacology, Intensive care medicine, Clinical trial, Immunology and Psychiatry. The studies on Clinical trial discussed at the most cited publications can also contribute to research in the domains of Cancer research, Drug development, Neuroprotection, Pharmacotherapy and Physical therapy. While Immunology is the focus of the most cited articles, it also provides insights into the studies of Dermatology, Disease and Transplantation.
The journal generally zeroes in on subjects such as Internal medicine, Oncology, Clinical trial, Immune checkpoint inhibitors and Cancer research. The studies in Oncology featured incorporate elements of Chemotherapy, Targeted therapy, Disease, Biological therapies and Immunotherapy. Antisense oligonucleotides and Neuroscience are some topics wherein Disease research discussed in it have an impact.
Issues in Clinical trial were discussed, taking into consideration concepts from other disciplines like Recombinant factor viii, Joint damage, Rilpivirine and Intensive care medicine. Expert Opinion on Emerging Drugs facilitates the exploration of Intensive care medicine in relation to the field of Phase (combat). The work on Immune system tackled in the journal brings together disciplines like Protein Tyrosine Kinase Inhibitors, Pharmacology, Protein kinase A and Arthritis.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Expert Opinion on Emerging Drugs (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Expert Opinion on Emerging Drugs (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 19.23% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.29% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.52% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.05% of all publications and 57.14% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
As the topics discussed in Expert Opinion on Emerging Drugs journal are primarily related to Internal Medicine, Immunology, Intensive Care, Pharmacology, and various diseases, it is advisable to also include details about how this knowledge interfaces with practical applications in healthcare. For instance, it would have been an enriching read if it was discussed how these emerging drugs can be applied in various nursing practices. This information could prove to be highly beneficial for readers who are either pursuing or planning to study in nursing schools. For instance, students aiming for a career in nursing can ideally look for resources or enroll in one of the online nursing schools in best online nursing programs in Nebraska and select a program that best suits their required expertise related to different medical fields such as Oncology, Cardiology, Intensive Care, etc. Moreover, practicing nurses can also utilize this knowledge to bolster their skillset when handling the direct administration of these emerging drugs, improve their patient care methodologies, and surpass the complex challenges in their everyday job roles. Therefore, the potential applications of the research featured in Expert Opinion on Emerging Drugs can hold a significant influence over the practical healthcare industry, especially nursing. This coherence can enhance the value that this research offers and meets its goal of enriching our understanding of these emerging drugs and their impact in the medical world.
Madia Lozupone;Vincenzo Solfrizzi;Francesca D’Urso;Ilaria Di Gioia
(2020)Priyanka Karagaiah;Yan Valle;Julia Sigova;Nicola Zerbinati
(2020)Amna Majeed;Jiaqi Xiong;Kayla M. Teopiz;Jason Ng
(2021)Toshio Fujino;Kenichi Suda;Tetsuya Mitsudomi
(2020)Esther A. Balogh;Arjun M. Bashyam;Rima I. Ghamrawi;Steven R. Feldman
(2020)Federica Lo Bello;Philip M Hansbro;Philip M Hansbro;Philip M Hansbro;Chantal Donovan;Chantal Donovan;Chantal Donovan;Irene Coppolino
(2020)Domenica Lorusso;Valentina Ceni;Valentina Ceni;Margherita Muratore;Margherita Muratore;Vanda Salutari
(2020)Ankelien Duchow;Ankelien Duchow;Claudia Chien;Friedemann Paul;Friedemann Paul;Judith Bellmann-Strobl;Judith Bellmann-Strobl
(2020)For those exploring Medicine in the USA, understanding complementary online degrees can broaden career opportunities. For instance, pursuing a fast track nutrition degree offers a quick path to roles in dietetics and wellness, closely linked to patient care and preventive health.
Healthcare professionals interested in leadership may consider an cheapest online MBA healthcare management. This degree supports advancement into administrative roles, merging clinical insight with business acumen to improve healthcare systems efficiently.
For non-nurses aiming to enter nursing, online BSN programs for non nurses provide accelerated options to obtain a Bachelor of Science in Nursing, enabling a faster transition into clinical nursing roles.
Lastly, for those specializing in mental health, exploring career prospects like psychiatric nursing is vital. Understanding psychiatric nurse practitioner salary by state can help gauge the financial benefits and job market trends in this growing field.
